19-5914459-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_004058.5(CAPS):c.53G>A(p.Arg18His) variant causes a missense change. The variant allele was found at a frequency of 0.0131 in 1,612,424 control chromosomes in the GnomAD database, including 191 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0084 ( 14 hom., cov: 33)
Exomes 𝑓: 0.014 ( 177 hom. )
Consequence
CAPS
NM_004058.5 missense
NM_004058.5 missense
Scores
3
4
8
Clinical Significance
Conservation
PhyloP100: 4.85
Genes affected
CAPS (HGNC:1487): (calcyphosine) This gene encodes a calcium-binding protein, which may play a role in the regulation of ion transport. A similar protein was first described as a potentially important regulatory protein in the dog thyroid and was termed as R2D5 antigen in rabbit. Alternative splicing of this gene generates two transcript variants. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.009452552).
BP6
Variant 19-5914459-G-A is Benign according to our data. Variant chr19-5914459-G-A is described in ClinVar as [Benign]. Clinvar id is 781743.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. gnomad4_exome allele frequency = 0.0136 (19907/1460126) while in subpopulation NFE AF= 0.016 (17785/1111432). AF 95% confidence interval is 0.0158. There are 177 homozygotes in gnomad4_exome. There are 9497 alleles in male gnomad4_exome subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 14 gene
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CAPS | ENST00000588776.8 | c.53G>A | p.Arg18His | missense_variant | 2/5 | 1 | NM_004058.5 | ENSP00000465883.2 | ||
ENSG00000267314 | ENST00000588891.1 | n.*148G>A | non_coding_transcript_exon_variant | 3/4 | 4 | ENSP00000468419.1 | ||||
ENSG00000267314 | ENST00000588891.1 | n.*148G>A | 3_prime_UTR_variant | 3/4 | 4 | ENSP00000468419.1 |
Frequencies
GnomAD3 genomes AF: 0.00840 AC: 1278AN: 152180Hom.: 14 Cov.: 33
GnomAD3 genomes
AF:
AC:
1278
AN:
152180
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00808 AC: 2020AN: 250124Hom.: 15 AF XY: 0.00812 AC XY: 1100AN XY: 135504
GnomAD3 exomes
AF:
AC:
2020
AN:
250124
Hom.:
AF XY:
AC XY:
1100
AN XY:
135504
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0136 AC: 19907AN: 1460126Hom.: 177 Cov.: 33 AF XY: 0.0131 AC XY: 9497AN XY: 726202
GnomAD4 exome
AF:
AC:
19907
AN:
1460126
Hom.:
Cov.:
33
AF XY:
AC XY:
9497
AN XY:
726202
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00838 AC: 1277AN: 152298Hom.: 14 Cov.: 33 AF XY: 0.00756 AC XY: 563AN XY: 74474
GnomAD4 genome
AF:
AC:
1277
AN:
152298
Hom.:
Cov.:
33
AF XY:
AC XY:
563
AN XY:
74474
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
60
ALSPAC
AF:
AC:
62
ESP6500AA
AF:
AC:
12
ESP6500EA
AF:
AC:
130
ExAC
AF:
AC:
979
Asia WGS
AF:
AC:
4
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 26, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
CAPS-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 09, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Pathogenic
DEOGEN2
Benign
.;.;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Pathogenic
D;D;D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
PrimateAI
Uncertain
T
REVEL
Benign
Sift4G
Pathogenic
D;D;D
Vest4
MVP
ClinPred
T
GERP RS
Varity_R
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at